Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-03-29 Purchase | 2022-03-31 5:29 pm | SOLENO THERAPEUTICS INC | SLNO | Sinclair Andrew Director | 7,720,000 | $0 | $0 | 25,742,602 (Indirect) | View |
2022-01-31 Purchase | 2022-02-01 5:04 pm | Sierra Oncology Inc. | SRRA | Sinclair Andrew Director | 150,000 | $27 | $4,050,000 | 1,314,127 (Indirect) | View |
2021-12-08 Purchase(A) | 2021-12-13 6:00 pm | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 500,000 | $14 | $7,000,000 | 2,115,385 (Indirect) | View |
2021-12-08 Purchase | 2021-12-10 5:30 pm | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 500,000 | $14 | $7,000,000 | 2,140,721 (Indirect) | View |
2020-06-26 Purchase | 2020-07-06 4:03 pm | SOLENO THERAPEUTICS INC | SLNO | Sinclair Andrew Director | 3,333,330 | $1.65 | $5,499,995 | 10,302,602 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-21 Option Award | 2024-08-23 4:08 pm | N/A 2031-03-01 | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 100,400 | $0 | 100,400 (Direct) | View |
2024-08-21 Disposition | 2024-08-23 4:08 pm | N/A 2031-03-01 | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 100,400 | $0 | 100,400 (Direct) | View |
2024-06-06 Option Award | 2024-06-10 8:51 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Sinclair Andrew Director | 6,500 | $0 | 6,500 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:03 pm | N/A 2034-06-04 | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 32,300 | $0 | 38,200 (Direct) | View |
2023-08-14 Option Award | 2023-08-16 6:07 pm | N/A 2031-03-01 | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 100,400 | $0 | 100,400 (Direct) | View |
2023-08-14 Disposition | 2023-08-16 6:07 pm | N/A 2031-03-01 | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 100,400 | $0 | 100,400 (Direct) | View |
2023-06-01 Option Award | 2023-06-02 5:46 pm | N/A 2033-05-31 | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 32,300 | $0 | 2,147,685 (Direct) | View |
2023-05-25 Option Award | 2023-05-26 6:30 pm | N/A 2033-05-25 | SOLENO THERAPEUTICS INC | SLNO | Sinclair Andrew Director | 12,666 | $0 | 12,666 (Direct) | View |
2022-06-01 Option Award | 2022-10-14 6:31 pm | N/A 2032-06-01 | SOLENO THERAPEUTICS INC | SLNO | Sinclair Andrew Director | 2,666 | $0 | 2,666 (Direct) | View |
2022-07-01 Disposition | 2022-07-01 4:44 pm | 2019-11-13 2024-11-13 | Sierra Oncology Inc. | SRRA | Sinclair Andrew Director | 871,125 | $45.98 | 0 (Indirect) | View |
2022-07-01 Disposition | 2022-07-01 4:44 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Sinclair Andrew Director | 1,314,127 | $55 | 0 (Indirect) | View |
2022-07-01 Disposition | 2022-07-01 4:44 pm | N/A 2029-11-29 | Sierra Oncology Inc. | SRRA | Sinclair Andrew Director | 14,374 | $0 | 0 (Direct) | View |
2022-06-02 Option Award | 2022-06-03 4:41 pm | N/A 2032-06-01 | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 18,500 | $0 | 18,500 (Direct) | View |
2022-01-28 Exercise | 2022-02-01 5:04 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Sinclair Andrew Director | 287,471 | $13.2 | 1,314,127 (Indirect) | View |
2022-01-28 Exercise | 2022-02-01 5:04 pm | 2020-01-22 N/A | Sierra Oncology Inc. | SRRA | Sinclair Andrew Director | 287,471 | $0 | 1,314,127 (Indirect) | View |
2021-08-09 Option Award | 2021-08-10 4:42 pm | N/A 2031-08-08 | Verona Pharma plc | VRNA | Sinclair Andrew Director | 64,000 | $0 | 64,000 (Direct) | View |
2021-06-08 Option Award | 2021-06-09 10:24 am | N/A 2031-06-08 | Sierra Oncology Inc. | SRRA | Sinclair Andrew Director | 6,000 | $0 | 6,000 (Direct) | View |
2021-06-01 Option Award | 2021-06-04 4:29 pm | N/A 2021-06-01 | SOLENO THERAPEUTICS INC | SLNO | Sinclair Andrew Director | 31,862 | $0 | 31,862 (Direct) | View |
2021-04-30 Option Award | 2021-05-04 7:26 pm | N/A 2031-04-29 | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 26,672 | $0 | 26,672 (Direct) | View |
2021-03-02 Option Award(A) | 2021-03-16 7:07 pm | N/A 2031-03-01 | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 28,828 | $0 | 1,644,213 (Direct) | View |
Ownership(A) | 2021-03-16 7:06 pm | N/A N/A | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 0 | $0 | 1,615,385 (Indirect) | View |
2021-03-02 Option Award | 2021-03-04 5:18 pm | N/A 2031-03-01 | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 28,828 | $0 | 1,669,549 (Direct) | View |
Ownership | 2021-03-04 5:17 pm | N/A N/A | Adicet Bio Inc. | ACET | Sinclair Andrew Director | 0 | $0 | 1,640,721 (Indirect) | View |
2021-01-08 Option Award | 2021-01-12 9:41 pm | N/A 2031-01-08 | SOLENO THERAPEUTICS INC | SLNO | Sinclair Andrew Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership(A) | 2021-01-05 5:15 pm | N/A N/A | Verona Pharma plc | VRNA | Sinclair Andrew Director | 0 | $0 | 21,064,222 (Indirect) | View |
Ownership | 2021-01-04 8:25 pm | N/A 2030-09-24 | Verona Pharma plc | VRNA | Sinclair Andrew Director | 0 | $0 | 185,600 (Direct) | View |
2020-06-09 Option Award | 2020-06-10 4:05 pm | N/A 2030-06-09 | Sierra Oncology Inc. | SRRA | Sinclair Andrew Director | 6,874 | $0 | 6,874 (Direct) | View |
2020-05-18 Option Award | 2020-05-20 5:47 pm | N/A 2030-05-18 | SOLENO THERAPEUTICS INC | SLNO | Sinclair Andrew Director | 9,530 | $0 | 9,530 (Direct) | View |
2020-01-29 Conversion(A) | 2020-02-03 4:14 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Sinclair Andrew Director | 882,740 | $0 | 876,656 (Indirect) | View |
2020-01-29 Conversion | 2020-01-31 8:15 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Sinclair Andrew Director | 882,625 | $0 | 876,542 (Indirect) | View |